Roger H. Kobayashi
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 13
- Immunology and Allergy top 10%
- Allergic Rhinitis and Sensitization 3
- Hematology top 10%
- Platelet Disorders and Treatments 5
- Genetics top 10%
- Blood disorders and treatments 6
- Physiology top 10%
- Asthma and respiratory diseases 6
-
- Respiratory and Cough-Related Research 6
- Cystic Fibrosis Research Advances 3
-
- Respiratory viral infections research 2
- Co-authors
- Ai KobayashiRebecca H. BuckleyM. Louise MarkertChristine L. HatemAbraham AbuchowskiMichael S. HershfieldAlton L. MeltonRichard I. Schiff
- Partner nations
- United StatesGermanyCzechia
In The Last Decade
Roger H. Kobayashi
27 papers receiving 686 citations
Peers
Comparison fields: 5 of 91
- Immunology 281
- Immunology and Allergy 59
- Hematology 106
- Genetics 189
- Physiology 28
Countries citing papers authored by Roger H. Kobayashi
This map shows the geographic impact of Roger H. Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger H. Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger H. Kobayashi more than expected).
Fields of papers citing papers by Roger H. Kobayashi
This network shows the impact of papers produced by Roger H. Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger H. Kobayashi. The network helps show where Roger H. Kobayashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roger H. Kobayashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2019 | 15 | |
| 3 | 2018 | 16 | |
| 4 | 2017 | 9 | |
| 5 | 2017 | 10 | |
| 6 | 2016 | 23 | |
| 7 | 2012 | 35 | |
| 8 | 2006 | 10 | |
| 9 | 2002 | 48 | |
| 10 | 1997 | 7 | |
| 11 | 1997 | 13 | |
| 12 | 1996 | 3 | |
| 13 | 1995 | 28 | |
| 14 | 1991 | 8 | |
| 15 | 1990 | 1 | |
| 16 | 1989 | 27 | |
| 17 | 1987 | 338 | |
| 18 | 1986 | 24 | |
| 19 | 1984 | 1 | |
| 20 | 1980 | 7 |
About Roger H. Kobayashi
Roger H. Kobayashi is a scholar working on Hematology, Immunology and Immunology and Allergy, having authored 28 papers that have together received 744 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (13 papers), Respiratory and Cough-Related Research (6 papers), Blood disorders and treatments (6 papers), Asthma and respiratory diseases (6 papers), Platelet Disorders and Treatments (5 papers), Allergic Rhinitis and Sensitization (3 papers), Cystic Fibrosis Research Advances (3 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Immunology (281 citations), Immunology and Allergy (59 citations) and Hematology (106 citations). Roger H. Kobayashi has collaborated with scholars based in United States, Germany and Czechia. Frequent co-authors include Ai Kobayashi, Rebecca H. Buckley, M. Louise Markert, Christine L. Hatem, Abraham Abuchowski, Michael S. Hershfield, Alton L. Melton, Richard I. Schiff, Joanne Kurtzberg and Michael Greenberg. Their work appears in journals such as New England Journal of Medicine, PEDIATRICS and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.